SG11202107416PA - Integration of nucleic acid constructs into eukaryotic cells with a transposase from oryzias - Google Patents
Integration of nucleic acid constructs into eukaryotic cells with a transposase from oryziasInfo
- Publication number
- SG11202107416PA SG11202107416PA SG11202107416PA SG11202107416PA SG11202107416PA SG 11202107416P A SG11202107416P A SG 11202107416PA SG 11202107416P A SG11202107416P A SG 11202107416PA SG 11202107416P A SG11202107416P A SG 11202107416PA SG 11202107416P A SG11202107416P A SG 11202107416PA
- Authority
- SG
- Singapore
- Prior art keywords
- oryzias
- transposase
- integration
- nucleic acid
- eukaryotic cells
- Prior art date
Links
- 241000276568 Oryzias Species 0.000 title 1
- 102000008579 Transposases Human genes 0.000 title 1
- 108010020764 Transposases Proteins 0.000 title 1
- 210000003527 eukaryotic cell Anatomy 0.000 title 1
- 230000010354 integration Effects 0.000 title 1
- 150000007523 nucleic acids Chemical class 0.000 title 1
- 102000039446 nucleic acids Human genes 0.000 title 1
- 108020004707 nucleic acids Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1082—Preparation or screening gene libraries by chromosomal integration of polynucleotide sequences, HR-, site-specific-recombination, transposons, viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
- C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
- C12N9/0026—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on CH-NH groups of donors (1.5)
- C12N9/0028—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on CH-NH groups of donors (1.5) with NAD or NADP as acceptor (1.5.1)
- C12N9/003—Dihydrofolate reductase [DHFR] (1.5.1.3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1025—Acyltransferases (2.3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1025—Acyltransferases (2.3)
- C12N9/1029—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1241—Nucleotidyltransferases (2.7.7)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/93—Ligases (6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y105/00—Oxidoreductases acting on the CH-NH group of donors (1.5)
- C12Y105/01—Oxidoreductases acting on the CH-NH group of donors (1.5) with NAD+ or NADP+ as acceptor (1.5.1)
- C12Y105/01003—Dihydrofolate reductase (1.5.1.3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
- C12Y207/01—Phosphotransferases with an alcohol group as acceptor (2.7.1)
- C12Y207/01119—Hygromycin-B 7''-O-kinase (2.7.1.119)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
- C12Y207/07—Nucleotidyltransferases (2.7.7)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y603/00—Ligases forming carbon-nitrogen bonds (6.3)
- C12Y603/01—Acid-ammonia (or amine)ligases (amide synthases)(6.3.1)
- C12Y603/01002—Glutamate-ammonia ligase (6.3.1.2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/90—Vectors containing a transposable element
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/007—Vector systems having a special element relevant for transcription cell cycle specific enhancer/promoter combination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/42—Vector systems having a special element relevant for transcription being an intron or intervening sequence for splicing and/or stability of RNA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
- C12N2840/203—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Virology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Veterinary Medicine (AREA)
- Crystallography & Structural Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962831092P | 2019-04-08 | 2019-04-08 | |
US201962873338P | 2019-07-12 | 2019-07-12 | |
US202062982186P | 2020-02-27 | 2020-02-27 | |
PCT/US2020/027080 WO2020210239A1 (en) | 2019-04-08 | 2020-04-07 | Integration of nucleic acid constructs into eukaryotic cells with a transposase from oryzias |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202107416PA true SG11202107416PA (en) | 2021-08-30 |
Family
ID=72663493
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202107416PA SG11202107416PA (en) | 2019-04-08 | 2020-04-07 | Integration of nucleic acid constructs into eukaryotic cells with a transposase from oryzias |
Country Status (11)
Country | Link |
---|---|
US (3) | US11060098B2 (ko) |
EP (1) | EP3953481A4 (ko) |
JP (1) | JP7418470B2 (ko) |
KR (1) | KR20210143897A (ko) |
CN (2) | CN112424362B (ko) |
AU (1) | AU2020272668B2 (ko) |
BR (1) | BR112021020143A2 (ko) |
CA (1) | CA3125047A1 (ko) |
IL (2) | IL301620A (ko) |
SG (1) | SG11202107416PA (ko) |
WO (1) | WO2020210239A1 (ko) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL140701A0 (en) | 1998-07-13 | 2002-02-10 | Univ Texas | Cancer treatment methods using antibodies to aminophospholipids |
CN112424362B (zh) | 2019-04-08 | 2024-07-23 | Dna2.0股份有限公司 | 使用来自青鳉属的转座酶将核酸构建体整合入真核细胞 |
WO2020210236A1 (en) | 2019-04-08 | 2020-10-15 | Dna Twopointo Inc. | Transposition of nucleic acids into eukaryotic genomes with a transposase from heliothis |
JP7418469B2 (ja) | 2019-04-08 | 2024-01-19 | ディーエヌエー ツーポイントオー インク. | アミエロイス由来のトランスポザーゼを用いた核酸コンストラクトの真核生物のゲノムへの転移 |
EP4146798A1 (en) | 2020-05-04 | 2023-03-15 | Saliogen Therapeutics, Inc. | Transposition-based therapies |
EP4314302A1 (en) * | 2021-03-24 | 2024-02-07 | Dna Twopointo Inc. | Tetracycline-inducible expression systems |
IL311782A (en) * | 2021-10-04 | 2024-05-01 | Poseida Therapeutics Inc | Transposases and their uses |
CN114045305B (zh) * | 2021-10-15 | 2023-03-24 | 深圳市深研生物科技有限公司 | 多转座子系统 |
CN116445542A (zh) * | 2022-01-10 | 2023-07-18 | 佛山汉腾生物科技有限公司 | 表达载体及其应用 |
CN115521899A (zh) * | 2022-05-06 | 2022-12-27 | 西南大学 | 一种高效的日本青鱂体外培养细胞CRISPR/Cas9基因组编辑方法及其应用 |
WO2024068995A1 (en) | 2022-09-30 | 2024-04-04 | Boehringer Ingelheim International Gmbh | Novel transposase system |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7560542B2 (en) * | 1999-05-07 | 2009-07-14 | Monsanto Technology Llc | Nucleic acid molecule SEQ ID NO. 68811 and other molecules associated with plants |
JP4629162B2 (ja) * | 1999-12-03 | 2011-02-09 | 独立行政法人科学技術振興機構 | トランスポゾン転移酵素および遺伝子改変方法 |
US7932088B1 (en) | 2005-04-25 | 2011-04-26 | University Of Notre Dame Du Lac | High efficiency transformation of Plasmodium falciparum by the lepidopteran transposon, piggyBac |
US20100154070A1 (en) * | 2005-05-14 | 2010-06-17 | Tian Xu | PiggyBac as a Tool for Genetic Manipulation and Analysis in Vertebrates |
JP4588681B2 (ja) * | 2006-09-15 | 2010-12-01 | 株式会社日立国際電気 | 無線基地局 |
WO2008072540A1 (ja) * | 2006-12-13 | 2008-06-19 | National University Corporation Nagoya University | Tol1因子のトランスポザーゼ及びそれを用いたDNA導入システム |
CA2692501C (en) * | 2007-07-04 | 2017-10-10 | Max-Delbrueck-Centrum Fuer Molekulare Medizin | Hyperactive variants of the transposase protein of the transposon system sleeping beauty |
CA2750027C (en) * | 2009-01-23 | 2020-11-10 | Nsgene A/S | Improved cell lines and their use in encapsulated cell biodelivery |
SG174155A1 (en) | 2009-02-25 | 2011-10-28 | Univ Johns Hopkins | Piggybac transposon variants and methods of use |
KR101812348B1 (ko) * | 2009-06-11 | 2017-12-26 | 다이가쿠쿄도리요우키칸호우진 죠우호우시스테무 겡큐키코우 | 단백질의 생산 방법 |
AU2013204327B2 (en) * | 2012-04-20 | 2016-09-01 | Aviagen | Cell transfection method |
JP2014230515A (ja) * | 2013-05-29 | 2014-12-11 | 国立大学法人 東京大学 | 新規なトランスポゾン転移酵素 |
WO2015157579A2 (en) * | 2014-04-09 | 2015-10-15 | Dna2.0, Inc. | Enhanced nucleic acid constructs for eukaryotic gene expression |
US10344285B2 (en) * | 2014-04-09 | 2019-07-09 | Dna2.0, Inc. | DNA vectors, transposons and transposases for eukaryotic genome modification |
DK3359671T3 (da) * | 2015-10-08 | 2021-09-20 | Dna Twopointo Inc | Dna-vektorer, transposoner og transposaser til eukaryot genommodifikation |
CN112424362B (zh) | 2019-04-08 | 2024-07-23 | Dna2.0股份有限公司 | 使用来自青鳉属的转座酶将核酸构建体整合入真核细胞 |
WO2020210236A1 (en) | 2019-04-08 | 2020-10-15 | Dna Twopointo Inc. | Transposition of nucleic acids into eukaryotic genomes with a transposase from heliothis |
JP7418469B2 (ja) | 2019-04-08 | 2024-01-19 | ディーエヌエー ツーポイントオー インク. | アミエロイス由来のトランスポザーゼを用いた核酸コンストラクトの真核生物のゲノムへの転移 |
CN114127083A (zh) * | 2019-05-13 | 2022-03-01 | Dna2.0股份有限公司 | 使用人工微rna修饰哺乳动物细胞以改变其特性及其产品的组成 |
CA3173696A1 (en) * | 2020-07-17 | 2022-01-20 | Volker Sandig | Hyperactive transposons and transposases |
-
2020
- 2020-04-07 CN CN202080003848.3A patent/CN112424362B/zh active Active
- 2020-04-07 IL IL301620A patent/IL301620A/en unknown
- 2020-04-07 AU AU2020272668A patent/AU2020272668B2/en active Active
- 2020-04-07 JP JP2021560153A patent/JP7418470B2/ja active Active
- 2020-04-07 CA CA3125047A patent/CA3125047A1/en active Pending
- 2020-04-07 CN CN202410889820.4A patent/CN118667845A/zh active Pending
- 2020-04-07 WO PCT/US2020/027080 patent/WO2020210239A1/en unknown
- 2020-04-07 KR KR1020217035083A patent/KR20210143897A/ko not_active Application Discontinuation
- 2020-04-07 SG SG11202107416PA patent/SG11202107416PA/en unknown
- 2020-04-07 BR BR112021020143A patent/BR112021020143A2/pt unknown
- 2020-04-07 IL IL287089A patent/IL287089B2/en unknown
- 2020-04-07 EP EP20788172.3A patent/EP3953481A4/en active Pending
- 2020-04-07 US US16/842,719 patent/US11060098B2/en active Active
-
2021
- 2021-06-04 US US17/339,617 patent/US11401521B2/en active Active
-
2022
- 2022-06-03 US US17/832,409 patent/US20230103199A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
JP7418470B2 (ja) | 2024-01-19 |
CA3125047A1 (en) | 2020-10-15 |
US20230103199A1 (en) | 2023-03-30 |
IL301620A (en) | 2023-05-01 |
EP3953481A4 (en) | 2023-01-25 |
US20210292773A1 (en) | 2021-09-23 |
IL287089A (en) | 2021-12-01 |
IL287089B1 (en) | 2023-05-01 |
US11401521B2 (en) | 2022-08-02 |
JP2022527017A (ja) | 2022-05-27 |
IL287089B2 (en) | 2023-09-01 |
KR20210143897A (ko) | 2021-11-29 |
US11060098B2 (en) | 2021-07-13 |
CN118667845A (zh) | 2024-09-20 |
US20200318121A1 (en) | 2020-10-08 |
EP3953481A1 (en) | 2022-02-16 |
AU2020272668A1 (en) | 2021-07-15 |
CN112424362A (zh) | 2021-02-26 |
BR112021020143A2 (pt) | 2021-12-14 |
WO2020210239A1 (en) | 2020-10-15 |
CN112424362B (zh) | 2024-07-23 |
AU2020272668B2 (en) | 2023-07-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL287089B1 (en) | Integration of nucleic acid constructs in eukaryotic cells with Oryzas transposases | |
EP3129487A4 (en) | Enhanced nucleic acid constructs for eukaryotic gene expression | |
IL287468A (en) | Nucleic acid structures and methods for their production | |
IL287088A (en) | Transposition of nucleic acid constructs into eukaryotic genomes with amylase transposases | |
EP3472359A4 (en) | NUCLEIC ACID SEQUENCING | |
IL273267A (en) | Carriers of DNA that do not undergo integration for genetic modification of cells | |
EP3222718A4 (en) | Method for knock-in of dna into target region of mammalian genome, and cell | |
EP3564389A4 (en) | METHOD FOR OBTAINING NUCLEIC ACIDS FROM FETAL CELLS | |
GB2581599B8 (en) | Tagging nucleic acid molecules from single cells for phased sequencing | |
EP3621640A4 (en) | OPTIMIZED NUCLEIC ACID ANTIBODIES CONSTRUCTIONS | |
EP3535400A4 (en) | PLASMIDIC VECTORS FOR EXPRESSION OF LARGE NUCLEIC ACID TRANSGENES | |
EP3953480A4 (en) | TRANSPOSITION OF NUCLEIC ACIDS INTO EUKARYOTIC GENOMES WITH A TRANSPOSASE FROM HELIOTHIS | |
EP3335310A4 (en) | ENERGY OBTAINED FROM FORCED NICKEL PIEZOELECTRIC RAYS | |
GB201812474D0 (en) | Nucleic acid construct | |
IL280465A (en) | Methods for gene modification of hematopoietic cells | |
EP4032551A4 (en) | NUCLEIC ACID COMPLEX | |
SG11202100455WA (en) | Recombinant nucleic acid construct | |
EP3762494A4 (en) | HIGH-PERFORMANCE NUCLEIC ACID PROFILING OF SINGLE CELLS | |
EP3766972A4 (en) | NUCLEIC ACID COMPLEX | |
GB201913898D0 (en) | Nucleic acid construct | |
HUE061202T2 (hu) | Ecetsav jelenlétében javított xilóz-fermentáló tulajdonsággal rendelkezõ élesztõtörzs | |
EP3845645A4 (en) | METHOD OF MODIFYING A TARGET NUCLEIC ACID IN THE GENOME OF A CELL | |
EP3802821A4 (en) | DIRECT NUCLEIC ACID SEQUENCING METHOD | |
AU2019902240A0 (en) | Isotachophoretic nucleic acid transformation of cells | |
EP3502232A4 (en) | CELL SCAFFOLDING MATERIAL WITH E-CADHERIN-BINDING NUCLEIC ACID APTAMER |